Amgen Inc (AMGN)
263.38
+2.19
(+0.84%)
USD |
NASDAQ |
Dec 20, 16:00
261.50
-1.88
(-0.71%)
After-Hours: 07:14
Amgen Cash from Investing (Quarterly): -210.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| Merck & Co Inc | -3.845B |
| Pfizer Inc | -2.057B |
| Regeneron Pharmaceuticals Inc | -574.40M |
| Viking Therapeutics Inc | 25.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.571B |
| Cash from Financing (Quarterly) | -3.651B |
| Free Cash Flow | 6.283B |
| Free Cash Flow Per Share (Quarterly) | 6.114 |
| Free Cash Flow to Equity (Quarterly) | 5.561B |
| Free Cash Flow to Firm (Quarterly) | 4.022B |
| Free Cash Flow Yield | 4.42% |